SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending due to its highly anticipated earnings report, with community discussion polarized between expectations of surging AI revenue and concerns over high valuation and potential post-earnings sell-offs mirroring other recent tech reports.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp ($BULL) is trending as the community eagerly awaits its earnings report, with discussions sharply divided between expectations of a long-overdue reversal fueled by strong fundamentals and perceived undervaluation, and deep skepticism due to consistent past price action and claims of market manipulation in the competitive fintech brokerage sector.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing (RGTI) is seeing significant attention driven by its imminent earnings report, intensifying a sharp divide within the community: bulls are emphasizing new government contracts and a solid cash position for its quantum future, while bears critically point to its high valuation, minimal revenue, and perceived technological delays, anticipating a post-earnings correction.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is surging as a substantial patent settlement removes a major legal overhang, while the FDA's reversal to review its flu vaccine application is driving bullish sentiment and sparking community talk of a massive short squeeze, with attention now turning to its promising oncology pipeline.

Okta, Inc. engages in the provision of an identity management platform for enterprises. It operates through the United States and International geographical segments. The firm's products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Okta is actively trending following its latest earnings report, which, despite an earnings and revenue beat with raised guidance, saw the stock decline due to investor concerns over the lack of fiscal 2027 outlook and broader AI disruption fears within the cybersecurity sector. The community is sharply divided, debating if the sell-off is an overreaction or if the stock will continue its historical underperformance.

Amprius Technologies, Inc. engages in the development, manufacture, and market lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the United States and Rest of the World geographical segments. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending following its recent earnings report, which signaled strong underlying business and sparked intense community debate on its true valuation amidst a one-time factory closure charge. Investors are keenly focused on AMPX's market-leading silicon-anode battery technology and strategic U.S. manufacturing partnerships, positioning it as a critical supplier within the rapidly expanding defense and drone sectors.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending due to escalating geopolitical tensions, which are spotlighting its advanced tactical drone systems, especially the Black Widow, amidst increasing defense sector demand and US Army initiatives. Community discussions center on the anticipation of significant contract awards and a potential short squeeze.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini (GEMI) is sparking significant community discussion after securing a CFTC Designated Contract Market license and launching its prediction market, leading to speculation about a short squeeze and its potential to ride a Bitcoin rally, even as past underperformance raises investor skepticism.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending upward after a Bank of America upgrade to Buy, fueled by optimism for its leadership in consumer autonomy, robotaxis, and the potential of its Optimus humanoid robots and energy segment. This has sparked a divided community discussion, with bulls anticipating further gains and a short squeeze, while bears highlight declining UK sales and perceived market manipulation.

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel C. Blackman in November 2018 and is headquartered in Brisbane, CA.

Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals is trending strongly on intensifying buyout speculation, fueled by robust OJEMDA sales, a solid cash position, recent preliminary EU approval for its lead drug, and unusual options activity, with the community actively debating potential acquisition valuations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The reverse split would reduce the number of outstanding shares from about 18.3 million to around 1.5 million.</li><li>This marks the company’s second reverse stock split since March 2024, when it carried out a 1-for-7 consolidation.</li><li>Lifeward’s board also approved increasing the authorized share capital to 100 million shares.</li></ul>Shares of Lifeward (LFWD) slumped nearly 20% to their all-time low after the company announced it would implement a 1-for-12 reverse stock split effective Feb. 24, 2026.<a href="https://stocktwits.com/symbol/LFWD">LFWD</a> stock will begin trading on a post-split basis the same day under the existing ticker symbol. The move is aimed at boosting the share price to regain compliance with Nasdaq’s $1.00 minimum bid price requirement.<h2 class="st-heading-2">Outstanding Shares To Be Reduced To Around 1.5 Million</h2>The move follows shareholder approval in January, which authorized the board to determine whether to implement a reverse split of the company’s outstanding ordinary shares and, if so, to set the ratio within a range of 1-for-2 to 1-for-12, giving the board full discretion over the outcome.Under the reverse split, every 12 ordinary shares will automatically convert into one share, reducing outstanding shares from about 18.3 million to around 1.5 million. The board also approved increasing the authorized share capital to 100 million shares.This marks the company’s second reverse split in nearly two years. In March 2024, Lifeward completed a 1-for-7 reverse split of its ordinary shares, reducing the number of outstanding shares from around 60.1 million to about 8.6 million.<h2 class="st-heading-2">Partnership With Oramed For Protein Oral Delivery Technology</h2>In January, Lifeward partnered with Oramed Pharmaceuticals (ORMP) to integrate Oramed’s proprietary POD protein oral delivery technology into its platform.Under the terms of the deal, Oramed could acquire up to a 49.99% equity stake in Lifeward. The investment structure is expected to provide Lifeward with access to up to $47 million in capital through a combination of equity, convertible notes, milestone-based funding, and warrant coverage, supporting future growth initiatives.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Meanwhile, retail sentiment on Stocktwits remained in the ‘neutral’ zone over the past 24 hours.Year-to-date, the stock has declined around 25%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/spai-stock-reverses-gains-safe-pro-us-government-ai-contract/cZRN7XMR4x0">This AI-Based Defense Company Secured A US Government Contract – So, Why Did The Stock Reverse Pre-Market Gains?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

LFWD Stock Sinks To Record Low On Second Reverse Split In Two Years

The company announced it would implement a 1-for-12 reverse stock split effective Feb. 24, 2026.

Equity

Oramed and Lifeward Announce Strategic Transaction

Oramed and Lifeward Announce Strategic Transaction Oramed and Lifeward Announce Strategic Transaction PR Newswire NEW YORK, Jan. 13, 2026 Transaction Will TransferOramed's Oral Drug Delivery Platform...

Lifeward Achieves European Approval for Latest ReWalk Exoskeleton

LFWD secures CE mark for its ReWalk 7 Personal Exoskeleton, unlocking new European sales potential with advanced features.

Lifeward (LFWD) Reports Q2 Loss, Lags Revenue Estimates

Lifeward (LFWD) delivered earnings and revenue surprises of -132.00% and -11.53%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Rigetti Computing, Inc. (RGTI) Reports Q2 Loss, Misses Revenue Estimates

Rigetti Computing (RGTI) delivered earnings and revenue surprises of +16.67% and -5.71%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Turtle Beach (TBCH) Reports Q2 Loss, Misses Revenue Estimates

Turtle Beach (TBCH) delivered earnings and revenue surprises of +48.15% and -0.80%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Verb Technology Company, Inc. (VERB) Reports Q2 Loss, Tops Revenue Estimates

Verb Technology (VERB) delivered earnings and revenue surprises of +12.25% and +51.64%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

8x8 (EGHT) Q1 Earnings Match Estimates

8x8 (EGHT) delivered earnings and revenue surprises of 0.00% and +2.36%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Nasdaq-listed shares of medical technology company Lifeward (LFWD) fell by about 2% on Monday afternoon after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.rewalk.com/news-releases/news-release-details/lifeward-names-mark-grant-new-ceo">announced</a> that Mark Grant was appointed its new President and CEO.The new appointment will be effective June 2, and Grant will replace Larry Jasinski. To help with the transition, Jasinski will serve as co-CEO and in an advisory capacity until June.Lifeward said he will continue in an advisory capacity on an as-needed basis until the end of 2025.Grant previously worked with Bristol Myers Squibb, FLA Orthopedics, and health tech company Medtronic.Most recently, Grant was President of the Americas and Chief Commercial Officer of IMRA Surgical, a provider of surgical robotic training.The company said that the Board of Directors has approved an inducement award of 400,000 options to purchase ordinary shares of Lifeward for Grant.The award will be made on the date he joins the company and vests in four equal annual installments beginning on the first anniversary of the new CEO’s joining date, subject to his continued employment with the company.Lifeward designs, develops, and commercializes solutions for individuals with physical limitations or disabilities, including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the MyoCycle FES System, and the ReStore Exo-Suit.The company recently launched the ReWalk 7, the newest generation of personal exoskeleton, in the U.S. market following FDA clearance in March.Earlier this month, Lifeward reported an adjusted net loss of $4.6 million, or $0.44 per share, in the first quarter of 2025, compared to a loss of $5.3 million, or $0.62 per share, during the first quarter of 2024. The company’s revenue for the three months through the end of March was $5 million.On Stocktwits, retail sentiment around Lifeward fell from ‘bearish’ to ‘extremely bearish’ territory over the past 24 hours while message volume remained at ‘high’ levels.<figure class="image"><img style="aspect-ratio:629/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_19_at_1_07_25_PM_png_38ed886908.webp" alt="LFWD's Sentiment Meter and Message Volume as of 1:05 p.m. ET on May 19, 2025 | Source: Stocktwits" width="629" height="61"><figcaption>LFWD's Sentiment Meter and Message Volume as of 1:05 p.m. ET on May 19, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/LFWD">LFWD stock</a> is down by 43% this year and over 74% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/netflix-stock-edges-lower-after-jp-morgan-downgrade-despite-higher-price-target/ch0cubqRb82">Netflix Stock Edges Lower After JPMorgan Downgrade Despite Higher Price Target</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

Lifeward Appoints Mark Grant As New CEO: Retail Sentiment Dips

Most recently, Grant was President of the Americas and Chief Commercial Officer of IMRA Surgical, a provider of surgical robotic training. 

Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates

Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.

LFWD
Rewalk Robotics Ltd.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LFWD News

LFWDRewalk Robotics Ltd.